UB-312 is a vaccine that targets alpha synuclein pathology by generating an immune response against pathological forms of alpha-synuclein, promoting its clearance from the brain.
Discover our Products
Science-based and high-quality devices
Science-based and high-quality devices
Your cart is currently empty.
Start Shopping